Skip to main content
Equibles

SILVERCREST ASSET MANAGEMENT GROUP LLC

Position in ZYME — Zymeworks Inc.

CIK 1232395 NEW YORK, NY
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,849,243
+$1,751,473 QoQ
Shares Held
223,766
+36.7% QoQ
Ownership
0.315%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#31
of 202 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 66% Shared 0% None 34%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SILVERCREST ASSET MANAGEMENT GROUP LLC holds $148,664,897 across 21 Biotechnology names. ZYME ranks #12 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VCEL
Vericel Corp
 896,651 $39,892,002
2 TWST
Twist Bioscience Corp
 196,496 $20,215,508
3 MIRM
Mirum Pharmaceuticals, Inc.
 77,278 $9,046,935
4 ARWR
Arrowhead Pharmaceuticals, Inc.
 103,616 $8,445,740
5 MDGL
Madrigal Pharmaceuticals, Inc.
 15,655 $8,405,952
6 RYTM
Rhythm Pharmaceuticals, Inc.
 73,432 $8,153,154
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 16,346 $8,119,548
8 COGT
Cogent Biosciences, Inc.
 159,545 $6,174,391

All Filings in ZYME

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,849,243 223,766
2026-03-31 $4,097,770 163,649
2025-12-31 $4,786,530 181,790
2025-09-30 $4,659,372 272,797
2025-06-30 $3,523,111 280,726
2025-03-31 $3,343,446 280,726
2024-12-31 $4,133,530 282,345
2024-09-30 $3,578,193 285,115
2024-06-30 $3,388,205 398,144
2024-03-31 $4,134,580 393,021
2023-12-31 $3,905,060 375,848
2023-09-30 $2,382,876 375,848
2023-06-30 $3,255,534 376,798